Drug class
Dibenzothiazepine antipsychotic; dopamine D2 receptor antagonist
Mechanism of action
Antagonises central dopamine D2 receptors and also interacts with serotonin, histamine and adrenergic receptors, reducing psychotic symptoms and contributing to sedative effects.
General use cases
- Treatment of acute psychotic disorders and schizophrenia in countries where clotiapine remains authorised; current availability and specific indications are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
